<p>Co-Diagnostics Inc. held a special meeting of shareholders on December 5, 2025. Shareholders approved an amendment to the Articles of Incorporation to authorize a reverse stock split of the company’s issued and outstanding shares of common stock, at a ratio to be determined by the Board within twelve months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-026385), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CODX

<p>Co-Diagnostics Inc. held a special shareholder meeting on December 5, 2025, where shareholders approved a reverse stock split proposal. The Board will determine the split ratio within twelve months. This information was published via EDGAR by Co-Diagnostics Inc.</p>

Co-Diagnostics Inc. held shareholder meeting on reverse stock split proposal